Investment Counselors of Maryland’s Lifecore Biomedical LFCR Stock Holding History

Investment Counselors of Maryland’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$13.9M	Buy	1,237,620 +97,743	+9%	+$1.13M	0.32%	105
2021 Q1	$12.1M	Buy	1,139,877 +38,973	+4%	+$438K	0.31%	104
2020 Q4	$11.9M	Buy	1,100,904 +56,908	+5%	+$588K	0.38%	103
2020 Q3	$10.1M	Buy	1,043,996 +126,141	+14%	+$1.2M	0.45%	100
2020 Q2	$7.31M	Buy	917,855 +63,724	+7%	+$658K	0.38%	100
2020 Q1	$7.42M	Buy	854,131 +1,717	+0.2%	+$17.9K	0.48%	92
2019 Q4	$9.64M	Buy	852,414 +14,722	+2%	+$157K	0.41%	99
2019 Q3	$9.11M	Sell	837,692 -2,208	-0.3%	-$24K	0.42%	100
2019 Q2	$7.87M	Buy	839,900 +9,217	+1%	+$93K	0.37%	102
2019 Q1	$10.2M	Buy	830,683 +32,861	+4%	+$401K	0.5%	94
2018 Q4	$9.45M	Buy	797,822 +17,800	+2%	+$244K	0.54%	93
2018 Q3	$11.2M	Buy	780,022 +185,444	+31%	+$2.56M	0.52%	93
2018 Q2	$8.86M	Buy	594,578 +217,824	+58%	+$3.03M	0.41%	99
2018 Q1	$4.92M	Buy	+376,754	New	+$4.95M	0.25%	102

Other funds holding LFCR

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

CSC

Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $551M AUM 49.99% 1-Year Est. Return

Investment Counselors of Maryland's LFCR Position: Q2 2021 in Review

Investment Counselors of Maryland increased its Lifecore Biomedical (LFCR) stake by 8.6% in Q2 2021, buying an estimated $1.13M and bringing the position to 1,237,620 shares worth $13.9M. The position accounts for 0.32% of the portfolio, ranked #105.

Investment Counselors of Maryland first reported a position in LFCR in Q1 2018 and has held it in 14 quarters since. 95 funds tracked by Wall St. Rank hold LFCR as of Q2 2021.

Investment Counselors of Maryland held 1,237,620 shares of Lifecore Biomedical worth $13.9M as of Q2 2021.
Investment Counselors of Maryland bought 97,743 Lifecore Biomedical shares in Q2 2021, an estimated $1.13M.
Lifecore Biomedical made up 0.32% of Investment Counselors of Maryland's portfolio in Q2 2021, its #105 holding.
Investment Counselors of Maryland first reported a position in Lifecore Biomedical in Q1 2018 and has held it in 14 quarters since.
95 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2021.

Based on Investment Counselors of Maryland's 13F filing for Q2 2021, filed 16 Jul 2021.